-
NHLF – Human Lung FibroblastsCatalog #: CC-2512
Cryopreserved ampule of Normal Human Lung Fibroblasts (NHLF) containing ≥ 500,000 cells
Do you need a modified version of this cell product, such as different vialing sizes, or isolations from special donors or species? Contact Lonza CellBio Services to discuss custom isolation, expansion, and testing options for your research
Sales unit: each -
-
Human Stellate Cell Growth MediaCatalog #: MCST250
Human Stellate Cell Growth Media
For use with cell product HUCLS and HUCLS1.
For HUCLS-200K and HUCLS-1M, please see MST-500BK, StGM Bullet KitTM
Sales unit: Bottle -
D-HBE-As – Diseased Human Bronchial/Tracheal Epithelial Cells – AsthmaCatalog #: 00194911D-HBE-As – Diseased Human Bronchial/Tracheal Epithelial Cells from donors having AsthmaSales unit: Ampule
-
HIAEC – Human Iliac Artery Endothelial CellsCatalog #: CC-2545HIAEC, Iliac Artery Endothelial CellsSales unit: each
-
Lung Fibroblast Cell Culture KitCatalog #: CC-2512B
Complete cell culture kit containing a cryopreserved ampule of lung fibroblast cells (catalog no. CC-2512) and FGMTM-2 BulletKitTM Fibroblast Growth Media (catalog no. CC-3132) for culture of lung fibroblast cells.
Sales unit: kit -
Human Peripheral Blood CD14+ Monocytes, Cryopreserved, Negative Selection, 10 millionCatalog #: 4W-400Cryopreserved ampule of Human Peripheral Blood CD14+ Monocytes, negative selection, containing ≥10 million cellsSales unit: each
-
Adult Keratinocyte Cell Culture KitCatalog #: 00192627BComplete cell culture kit containing a cryopreserved ampule of adult keratinocytes (00192627) and KGMTM Gold Growth Media BulletKitTM (00192060) for culture of keratinocytes.Sales unit: kit
-
TheraPEAK® SfAAV® MediumCatalog #: BP12-945Q
TheraPEAK® SfAAV® Medium for AAV production in SF9 cells, chemically defined, hydrolysate free, 1 L
Sales unit: Bottle -
EGM™-Plus Endothelial Cell Growth Medium - Plus SingleQuot™ Kits and Growth SupplementsCatalog #: CC-4542EGMTM Plus Endothelial SingleQuotTM KitSales unit: kit
-
Natural Killer Cells InfographicNatural Killer cells have an innate ability to recognize and destroy non-self cells.
-
3D Natural Killer Cell-mediated Cytotoxicity AssayLonza White Paper
-
3D Natural Killer (NK) Cell-mediated Cytotoxicity (CMC) Assay
-
Natural Killer (NK) Cell Expansion, Activation and Cytotoxicity AssayProtocol instructions
-
Therapeutic Approaches to Enhance Natural Killer Cell Cytotoxicity: The Force AwakensPoster published by Nature Reviews Drug Discovery, sponsored by Lonza. Natural killer (NK) cells are emerging as attractive candidates for new immunotherapeutic approaches. The poster shows the approaches to NK cell tumor targeting.
-
Transfection Protocol for Human NK Cells - Nucleofector™ I/II/2b Device SeriesInstructions of use for transfection of human natural killer cells with Nucleofector™ 1/2 Devices (incl. 1, 2b, 2N, 2S)
-
An Innovative, Highly Efficient Method for Transfecting Large Quantities of Primary Human T-cellsA strong need exists for improved cancer treatment options. Lonza's approach relies on genetically modified, patient-derived cells like T-cells or natural killer cells which express chimeric antigen receptors (CAR) targeting cancer cells.
-
NK Cell Assay using 3D Bioprinted Tumor ModelsThis white paper describes an ex vivo assay for NK cell killing activity in a 3D bioprinted cervical cancer tumor model.
-
TechSheet - Poietics™ Human Immune System CellsTechnical Product Information Sheet
-
CAR T cells in Cancer TherapyA poster developed by Nature Reviews in conjunction with Lonza to present CAR T cells in cancer therapy. This poster demonstrates the recognition of tumor peptides by T cells, CAR T cell manufacturing, the types of chimeric antigen receptors and a timeline of CAR development over more than 30 years.